ReviewJournal of thoracic disease2015
Left ventricular assist device driveline infections: recent advances and future goals.
Review in Journal of thoracic disease, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
34 citing papers in PubMed, 82 citations in OpenAlex.
- Handheld infrared thermography for triage of LVAD driveline infection: A prospective pilot diagnostic accuracy study.JHLT open · 2026Article
- Short-term outcomes of pediatric HeartMate 3 left ventricular assist device: single center experience.ESC heart failure · 2026Article
- Article
- Local Infections Associated with Ventricular Assist Devices: Materials-Related Challenges and Emerging Solutions.Materials (Basel, Switzerland) · 2025Review
- Identifying key CT features and clinical variables for predicting operative management of left ventricular assist device (LVAD) driveline infections.Emergency radiology · 2025Article
- Driveline Relocation and Vacuum-Assisted Closure for Ventricular Assist Device Driveline Infections.Journal of cardiovascular development and disease · 2025Article
- Impact of extracellular matrix scaffold on driveline infection rate in patients with left ventricular assist devices.JTCVS open · 2025Article
- Recent Developments in Ventricular Assist Device Therapy.Reviews in cardiovascular medicine · 2025Review
- [MSB-06] Retrospective Cohort Analysis of Ventricular Assist Device Driveline Infections: A Single-Center Experience.Turk gogus kalp damar cerrahisi dergisi · 2024Article
- Comparison of Dental Findings with Computed Tomographic and Clinical Examination in Patients with End-Stage Heart Failure.Journal of clinical medicine · 2024Article
- Anti-infective characteristics of a new Carbothane ventricular assist device driveline.Biofilm · 2023Article
- A Case Report of a LVAD Driveline Infection Diagnosed by Point-of-care Ultrasound.Clinical practice and cases in emergency medicine · 2023Article
- Modeling of intracranial tumor treating fields for the treatment of complex high-grade gliomas.Scientific reports · 2023Article
- Local Treatment of Driveline Infection with Bacteriophages.Antibiotics (Basel, Switzerland) · 2022Article
- Decreasing driveline infections in patients supported on ventricular assist devices: a care pathway approach.BMJ open quality · 2022Review
- Systems of conductive skin for power transfer in clinical applications.European biophysics journal : EBJ · 2022Review
- Prevalence and management of driveline infections in mechanical circulatory support - a single center analysis.Journal of cardiothoracic surgery · 2021Article
- Elimination of drive exit line: transcutaneous energy transmission.Annals of cardiothoracic surgery · 2021Article
- Outbreak of SARS-CoV-2: challenge for diagnosis and medical management in patients with left ventricular assist device: a case series.European heart journal. Case reports · 2021Article
- Management and Outcome of Left Ventricular Assist Device Infections in Patients Undergoing Cardiac Transplantation.Open forum infectious diseases · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
Abstract
Left ventricular assist devices (LVADs) have revolutionized the treatment of advanced heart failure, but infection remains a substantial risk. LVAD driveline infections (DLIs) are the most common type of LVAD-associated infection (LVADI). In the past several years we have expanded our understanding of DLI epidemiology, standardized the definition of LVADIs, improved infection rates through changes in implantation techniques, and investigated potential new modalities for DLI diagnosis. However, significant challenges remain for optimizing DLI prevention and treatment. These challenges include standardizing and improving both empiric and targeted antimicrobial therapy, expanding our understanding of effective driveline exit site dressings and topical therapies, and defining the patient population that benefits from device exchange and transplant. Additionally, in an era of expanding antibiotic resistance we need to continue investigating novel, non-antibiotic therapies for prevention and treatment of DLIs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.